| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | ALEXION PHARMACEUTICALS INC | Feb 5, 2026 | |
| Buy | ALEXION PHARMACEUTICAL REAL | Nov 19, 2025 | |
| Sell | ALTRIA GROUP, INC. CMN | Aug 4, 2025 | |
| Buy | ALEXION REAL ESTATE EQUITIES | Feb 19, 2025 | |
| Buy | ALEXION PHARMACEUTICALS INC | Aug 23, 2021 | |
| Sell | Alexion Pharmaceuticals, Inc | Jul 21, 2021 | |
| Buy | Alexion Pharmaceuticals, Inc | Jan 5, 2021 | |
| Sell | ALEXION PHARMACEUTICALS, UNC | Sep 1, 2020 | |
| Sell | ALEXION PHARMACEUTICALS INC | Aug 4, 2020 | |
| Buy | Alexion Pharmaceuticals, Inc | Jul 14, 2020 |
This page tracks congressional stock trading activity in Alexion Pharmaceuticals Inc (ALXN) in the Acquired sector. Disclosed Capitol has indexed 145 disclosed congressional trades involving ALXN. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of March 2026 — Disclosed Capitol has tracked 145 disclosed congressional trades in Alexion Pharmaceuticals Inc (ALXN) — 64:63 sell-heavy ratio — led by Michael McCaul (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| 2026-02-05 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| 2025-11-19 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| 2025-08-04 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| 2025-02-19 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| 2021-08-23 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| 2021-07-21 | Dean Phillips | D | Sale | $1,001 - $15,000 |
| 2021-01-05 | Dean Phillips | D | Buy | $1,001 - $15,000 |
| 2020-09-01 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| 2020-08-04 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| 2020-07-14 | Gilbert Cisneros | D | Buy | $1,001 - $15,000 |
Across the 145 disclosed congressional trades in Alexion Pharmaceuticals Inc (ALXN), members of Congress have reported 63 buys and 64 sells. The average 30-day alpha vs. the S&P 500 is -0.49%.